Pharmaceutical Sector-Government encourage the development of Chinese Medicine and healthcare
Friday, May 8, 2009 at 10:37AM
Newsflow. Chinese State Council issued “the opinion on supporting and encouraging the development of Chinese medicine and healthcare" yesterday. Based on the Opinion, the qualified Chinese medical clinical house and Chinese medicine product will be in the medical insurance list.
Related listco. Shineway (2877 HK, HK$5.25), Wuyi Pharma (1889 HK, HK$0.78) and Guangzhou Pharma (874 HK, HK$3.12) are current HK listco with Chinese medicine exposure. They are currently trading at 6.8x, 7.5x FY12/09F P/E and 16.1x FY12/09F P/E respectively based on market consensus and our estimate.
1889,
2877,
874,
Guangzhou Pharma,
Shineway,
Wuyi Pharma in
Healthcare 
Reader Comments